Literature DB >> 9369957

PTHrP and cell division: expression and localization of PTHrP in a keratinocyte cell line (HaCaT) during the cell cycle.

M H Lam1, S L Olsen, W A Rankin, P W Ho, T J Martin, M T Gillespie, J M Moseley.   

Abstract

Parathyroid hormone-related protein (PTHrP) is highly expressed in normal skin keratinocytes, and its involvement in growth and differentiation processes in these cells has been implicated by several lines of evidence which include the use of antisense PTHrP (Kaiser et al., 1994, Mol. Endocrinol., 8:139-147). In this study, we have investigated whether PTHrP expression and its subcellular localization is linked to cell cycle progression in a human keratinocyte cell line (HaCat), which constitutively expresses and secretes PTHrP. PTHrP mRNA and immunoreactive PTHrP were assessed in asynchronous dividing cells and in cells blocked at G1 or G2 + M phases of the cell cycle using several different protocols. The response of PTHrP mRNA expression was examined following readdition of serum in the continued presence of cycle blockers, and after release from cell cycle block, or from cell synchronization by serum deprivation. PTHrP expression was greatest in actively dividing cells when cells were in S and G2 + M phases of the cell cycle and were lowest in quiescent G1 cells. Most notable were the high levels of PTHrP mRNA and protein in cells at G2 + M phase of the cell cycle at division. Furthermore, PTHrP was localized to the nucleolus in quiescent cells, but redistributed to the cytoplasm when cells were actively dividing. Taken together, these results support a role for PTHrP in cell division in keratinocytes. In asynchronously growing cells, PTHrP expression fell as cells became confluent at a time when cell growth is inhibited and cells begin to differentiate. Mitogen stimulation of HaCaT cells resulted in a rapid increase in PTHrP mRNA expression, but was dependent upon cells being in the G1 phase of the cell cycle. Cells blocked in G1 responded to mitogen both in the continued presence of aphidicolin or when released from block. Cells blocked at G2 + M with colcemid expressed high levels of PTHrP mRNA and protein, and PTHrP mRNA did not respond further to mitogen in the continued presence of blocker. However, in cells released from block at G2 + M by addition of serum, an increase in PTHrP expression was seen coincident with the progression of cells into G1. In contrast, in a squamous cancer cell line (COLO16), basal PTHrP expression was high and was not altered during the cell cycle or by cell cycle block, consistent with association of its dysregulated expression in malignant cells. The results of this study suggest that PTHrP may have two roles in the cell cycle; one in G1 in response to mitogen, and a second at cell division when its expression is high and it is relocated from the nucleolus to the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9369957     DOI: 10.1002/(SICI)1097-4652(199712)173:3<433::AID-JCP16>3.0.CO;2-C

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  9 in total

Review 1.  Parathyroid hormone-related protein.

Authors:  R A Nissenson
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Platelet-activating factor induces proliferation in differentiated keratinocytes.

Authors:  Astrid J Feuerherm; Katarina M Jørgensen; Randi M Sommerfelt; Live E Eidem; Astrid Lægreid; Berit Johansen
Journal:  Mol Cell Biochem       Date:  2013-08-24       Impact factor: 3.396

3.  Immunohistochemical localization of parathyroid hormone-related protein (PTHrP) and serum PTHrP in normocalcemic patients with oral squamous cell carcinoma.

Authors:  Makoto Tsuchimochi; Ayako Kameta; Mikiko Sue; Masataka Katagiri
Journal:  Odontology       Date:  2005-09       Impact factor: 2.634

4.  Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo.

Authors:  P W M Ho; A Goradia; M R Russell; A M Chalk; K M Milley; E K Baker; J A Danks; J L Slavin; M Walia; B Crimeen-Irwin; R A Dickins; T J Martin; C R Walkley
Journal:  Oncogene       Date:  2014-07-21       Impact factor: 9.867

Review 5.  Twenty-five years of PTHrP progress: from cancer hormone to multifunctional cytokine.

Authors:  Laurie K McCauley; T John Martin
Journal:  J Bone Miner Res       Date:  2012-05-01       Impact factor: 6.741

6.  Parathyroid hormone-related protein production in the lamprey Geotria australis: developmental and evolutionary perspectives.

Authors:  Melanie K Trivett; Ian C Potter; Glenn Power; Hong Zhou; David L Macmillan; T John Martin; Janine A Danks
Journal:  Dev Genes Evol       Date:  2005-11-04       Impact factor: 0.900

7.  Nuclear variants of bone morphogenetic proteins.

Authors:  Jenny E Felin; Jaime L Mayo; Trina J Loos; J Daniel Jensen; Daniel K Sperry; Stephanie L Gaufin; Christopher A Meinhart; Jennie B Moss; Laura C Bridgewater
Journal:  BMC Cell Biol       Date:  2010-03-15       Impact factor: 4.241

8.  Severe growth retardation and early lethality in mice lacking the nuclear localization sequence and C-terminus of PTH-related protein.

Authors:  Dengshun Miao; Hanyi Su; Bin He; Jianjun Gao; Qingwen Xia; Min Zhu; Zhen Gu; David Goltzman; Andrew C Karaplis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-17       Impact factor: 11.205

9.  A Unique Panel of Patient-Derived Cutaneous Squamous Cell Carcinoma Cell Lines Provides a Preclinical Pathway for Therapeutic Testing.

Authors:  Sakinah Hassan; Karin J Purdie; Jun Wang; Catherine A Harwood; Charlotte M Proby; Celine Pourreyron; Nikol Mladkova; Ai Nagano; Sandeep Dhayade; Dimitris Athineos; Matthew Caley; Viviana Mannella; Karen Blyth; Gareth J Inman; Irene M Leigh
Journal:  Int J Mol Sci       Date:  2019-07-12       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.